Outlook Therapeutics Inc OTLK:NASDAQ

Last Price$1.02NASDAQ Closing Price as of 4:00PM ET 7/01/22

Today's Change0.00(0.00%)
Bid (Size)$1.00 (20)
Ask (Size)$1.05 (50)
Day Low / High$1.00 - 1.05
Volume376.8 K

Insider Buy: Outlook Therapeutics

5:45PM ET 2/23/2022 MT Newswires
Kurt J Hilzinger, Director, on February 22, 2022, executed a purchase for 175,132 shares in Outlook Therapeutics (OTLK) for $256,970. Following the Form 4 filing with the SEC, Hilzinger has control over a total of 198,249 shares of the company, with 198,249 shares held directly. The market value of the direct and indirect holding, based on the transaction price, is approximately $285,479.

SEC Filing:


Price: 1.54, Change: +0.13, Percent Change: +9.22